We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$6.3B
AUM Growth
+$270M
Cap. Flow
+$163M
Cap. Flow %
2.59%
Top 10 Hldgs %
21.06%
Holding
1,545
New
109
Increased
700
Reduced
529
Closed
115

Sector Composition

Rank Sector Weight
1 Technology 21.33%
2 Financials 9.67%
3 Industrials 8.24%
4 Healthcare 8.22%
5 Consumer Discretionary 7.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IONQ icon
1051
IonQ
IONQ
$13.6B
$430K 0.01%
61,175
+24,680
+68% +$202K
IPG
1052
DELISTED
Interpublic Group of Companies
IPG
$429K 0.01%
14,761
+466
+3% +$14.4K
HDV
1053
iShares Core High Dividend ETF
HDV
$14.5B
$427K 0.01%
19,625
-5,090
-21% -$111K
AVDL
1054
DELISTED
Avadel Pharmaceuticals
AVDL
$426K 0.01%
30,325
-6,770
-18% -$110K
SPEM icon
1055
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.2B
$426K 0.01%
11,303
-2,181
-16% -$81.2K
VBK icon
1056
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.1B
$425K 0.01%
1,701
-21
-1% -$5.24K
W icon
1057
Wayfair
W
$11.2B
$425K 0.01%
8,062
+1,605
+25% +$95.3K
ALB.PRA icon
1058
Albemarle Corp Depositary Shares
ALB.PRA
$2.29B
$425K 0.01%
+9,100
New +$493K
DBMF icon
1059
iMGP DBi Managed Futures Strategy ETF
DBMF
$3.98B
$423K 0.01%
14,064
+6,711
+91% +$198K
GGN
1060
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$766M
$422K 0.01%
104,200
EDV icon
1061
Vanguard World Funds Extended Duration ETF
EDV
$3.22B
$420K 0.01%
5,725
-3,486
-38% -$252K
TSEM icon
1062
Tower Semiconductor
TSEM
$24.8B
$420K 0.01%
10,680
WTFC icon
1063
Wintrust Financial
WTFC
$10.8B
$419K 0.01%
4,247
-629
-13% -$61.6K
CYTK icon
1064
Cytokinetics
CYTK
$10.5B
$418K 0.01%
7,722
-606
-7% -$36.6K
SIMS icon
1065
State Street SPDR S&P Kensho Intelligent Structures ETF
SIMS
$8.43M
$418K 0.01%
+12,565
New +$425K
ALNY icon
1066
Alnylam Pharmaceuticals
ALNY
$27.5B
$417K 0.01%
1,716
DOCS icon
1067
Doximity
DOCS
$3.76B
$417K 0.01%
14,895
-205
-1% -$5.41K
GNK icon
1068
Genco Shipping & Trading
GNK
$1.11B
$414K 0.01%
+19,448
New +$419K
BTT icon
1069
BlackRock Municipal 2030 Target Term Trust
BTT
$1.43B
$412K 0.01%
19,854
+92
+0.5% +$1.9K
BMEA icon
1070
Biomea Fusion
BMEA
$84.6M
$412K 0.01%
91,522
+77,818
+568% +$791K
FIS icon
1071
Fidelity National Information Services
FIS
$23.1B
$410K 0.01%
+5,434
New +$402K
AU icon
1072
AngloGold Ashanti
AU
$40.1B
$409K 0.01%
+16,268
New +$386K
BPT
1073
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$407K 0.01%
164,910
+74,290
+82% +$179K
OSCR icon
1074
Oscar Health
OSCR
$9.41B
$407K 0.01%
25,718
+6,268
+32% +$115K
SNY icon
1075
Sanofi
SNY
$103B
$406K 0.01%
8,370
-90
-1% -$4.34K

Similar funds

Oppenheimer & Co's Q2 2024 Portfolio in Review

As of Q2 2024, Oppenheimer & Co held 1,545 positions worth $6.3B, up 4.5% from $6.03B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Oppenheimer & Co's Q2 2024 filing shows 109 new, 700 increased, 529 reduced and 115 closed positions. Its largest new stake was FT Vest US Equity Deep Buffer ETF March: 599,727 shares worth $21.6M. The largest sale was FT Vest US Equity Deep Buffer ETF August, an estimated $20.5M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.

  • Oppenheimer & Co's largest Q2 2024 buy was FT Vest US Equity Deep Buffer ETF March: 599,727 shares worth $21.6M.
  • Oppenheimer & Co added most to Amazon in Q2 2024, an estimated $9.44M increase.
  • Oppenheimer & Co's biggest Q2 2024 reduction was FT Vest US Equity Deep Buffer ETF August, cutting an estimated $20.5M.
  • Oppenheimer & Co fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $6.69M.
  • Oppenheimer & Co's ten largest holdings make up 21% of its $6.3B portfolio in Q2 2024.
  • Oppenheimer & Co opened 109 new positions and closed 115 in Q2 2024.
  • Oppenheimer & Co's portfolio value rose 4.5% quarter-over-quarter to $6.3B.

Based on Oppenheimer & Co's 13F filing for Q2 2024, filed 8 Aug 2024.